|
|
| | LDN-27219 Basic information |
| Product Name: | LDN-27219 | | Synonyms: | LDN-27219;2-[(3,4-Dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-acetic acid hydrazide;CS-1194;LDN-27219
(LDN 27219;184663;2-((4-oxo-3,5-diphenyl-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetohydrazide;Acetic acid, 2-[(3,4-dihydro-4-oxo-3,5-diphenylthieno[2,3-d]pyrimidin-2-yl)thio]-, hydrazide;LDN-27219 >=98% (HPLC) | | CAS: | 312946-37-5 | | MF: | C20H16N4O2S2 | | MW: | 408.5 | | EINECS: | 604-604-1 | | Product Categories: | | | Mol File: | 312946-37-5.mol |  |
| | LDN-27219 Chemical Properties |
| density | 1.45±0.1 g/cm3(Predicted) | | storage temp. | -20°C | | solubility | DMSO: soluble15mg/mL, clear | | pka | 11.87±0.37(Predicted) | | form | powder | | color | white to beige |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 |
| | LDN-27219 Usage And Synthesis |
| Uses | LDN 27219 is a transglutaminase inhibitor. | | storage | Store at +4°C |
| | LDN-27219 Preparation Products And Raw materials |
|